{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-062800","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2025-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.179430+00:00","generated_at":"2026-05-18T08:43:57.229231+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Adial Pharmaceuticals regains Nasdaq equity compliance after $3.6M offering","bullets":["Received Nasdaq deficiency notice on May 23, 2025 for stockholders' equity of $2,126,662, below $2.5M minimum.","Completed June 18, 2025 offering raising ~$3.6M gross via shares and warrants at $0.3251 per unit.","Company believes it has now regained compliance with Nasdaq stockholders' equity requirement.","Nasdaq will continue to monitor compliance; further non-compliance could lead to delisting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-062800","json":"https://secwatch.observer/filing/0001213900-25-062800.json","markdown":"https://secwatch.observer/filing/0001213900-25-062800.md","text":"https://secwatch.observer/filing/0001213900-25-062800.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025062800/0001213900-25-062800-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025062800/ea0248566-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T08:43:57.229231+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}